BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Z, Zhangsun M, Dong S, Liu Y, Qian J, Zhangsun D, Luo S. Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA. Mar Drugs 2020;18:E61. [PMID: 31963558 DOI: 10.3390/md18010061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Elgoyhen AB. The α9α10 nicotinic acetylcholine receptor: A compelling drug target for hearing loss? Expert Opinion on Therapeutic Targets. [DOI: 10.1080/14728222.2022.2047931] [Reference Citation Analysis]
2 Carroll AR, Copp BR, Davis RA, Keyzers RA, Prinsep MR. Marine natural products. Nat Prod Rep 2022. [PMID: 35201245 DOI: 10.1039/d1np00076d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 26.0] [Reference Citation Analysis]
3 Murayama MA, Takada E, Takai K, Arimitsu N, Shimizu J, Suzuki T, Suzuki N. Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells. PLoS One 2022;17:e0260838. [PMID: 35085258 DOI: 10.1371/journal.pone.0260838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang H, Liang A, Pan X. Preparation and Functional Identification of a Novel Conotoxin QcMNCL-XIII0.1 from Conus quercinus. Toxins 2022;14:99. [DOI: 10.3390/toxins14020099] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Tsetlin V, Haufe Y, Safronova V, Serov D, Shadamarshan P, Son L, Shelukhina I, Kudryavtsev D, Kryukova E, Kasheverov I, Nicke A, Utkin Y. Interaction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms. Front Cell Neurosci 2021;15:765541. [PMID: 35002625 DOI: 10.3389/fncel.2021.765541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu HM, Ma LL, Li C, Cao B, Jiang Y, Han L, Xu R, Lin J, Zhang D. The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy. Transl Oncol 2022;15:101281. [PMID: 34875482 DOI: 10.1016/j.tranon.2021.101281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Yousuf A, Wu X, Bony AR, Sadeghi M, Huang YH, Craik DJ, Adams DJ. ɑO-Conotoxin GeXIVA isomers modulate N-type calcium (CaV 2.2) channels and inwardly-rectifying potassium (GIRK) channels via GABAB receptor activation. J Neurochem 2021. [PMID: 34738241 DOI: 10.1111/jnc.15535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Salimi A, Salehian S, Aboutorabi A, Vazirizadeh A, Adhami V, Sajjadi Alehashem SH, Seydi E, Pourahmad J. Cytotoxicity Studies of the Crude venom and Fractions of Persian Gulf Snail (Conus textile) on Chronic Lymphocytic Leukemia and Normal Lymphocytes. Asian Pac J Cancer Prev 2021;22:1523-9. [PMID: 34048181 DOI: 10.31557/APJCP.2021.22.5.1523] [Reference Citation Analysis]
9 Li Z, Han X, Hong X, Li X, Gao J, Zhang H, Zheng A. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2]. Mar Drugs 2021;19:121. [PMID: 33668830 DOI: 10.3390/md19030121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li X, Tae HS, Chu Y, Jiang T, Adams DJ, Yu R. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor. Pharmacol Ther 2021;222:107792. [PMID: 33309557 DOI: 10.1016/j.pharmthera.2020.107792] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
11 Sun Z, Bao J, Zhangsun M, Dong S, Zhangsun D, Luo S. αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors. Mar Drugs 2020;18:E195. [PMID: 32272701 DOI: 10.3390/md18040195] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]